Purification of O-specific polysaccharide from lipopolysaccharide produced by Salmonella enterica serovar Paratyphi A |
| |
Authors: | Sudeep Kothari Jeong-Ah Kim Neha Kothari Christopher Jones Woo Seok Choe Rodney Carbis |
| |
Institution: | 1. Vaccine Development Section, International Vaccine Institute, SNU Research Park, San 4-8, Nakseongdae-dong, Gwanak-gu, 151-919 Seoul, Republic of Korea;2. National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Potters Bar EN6 3QG, Hertfordshire, UK;3. School of Chemical Engineering, Sungkyunkwan University, Suwon 440-746, Republic of Korea |
| |
Abstract: | The O specific polysaccharide (OSP) of the lipopolysaccharide (LPS) of Salmonella enterica serovar Paratyphi A is a protective antigen and the target for vaccine development. LPS is the major constituent of the outer membrane of S. Paratyphi A with the OSP exposed on the surface, in addition to the cell associated LPS a large amount of free LPS was present in the fermentation broth. A purification method was developed to take advantage of both sources of LPS and to maximize recovery of OSP. After fermentation the bacterial cells were concentrated and washed, the permeate containing the free LPS was processed separately from the cells. The free LPS was concentrated and washed on a 100 kD ultrafiltration membrane to remove low molecular weight impurities. The LPS was then detoxified by separation of the lipid A from the OSP using acid hydrolysis at 100 °C, the precipitated lipid A was removed by 0.2 μm membrane filtration. Contaminants were then removed by acid precipitation in the presence of sodium deoxycholate. The OSP was concentrated and washed with 1 M NaCl then water using a 10 kD ultrafiltration membrane then sterile filtered through a 0.2 μm membrane filter. The cells were treated by acid hydrolysis at 100 °C, the remaining cells, cell debris and precipitate was removed by centrifugation. The filtrate was then treated in the same way as described above for the free LPS. The combined yield of purified OSP from free LPS plus the cells was greater than 880 mg/L of culture broth. The method developed yields large amounts of OSP, is scalable and compatible with cGMP so would be readily transferrable to developing country vaccine manufacturers for low cost production of vaccine against S. Paratyphi A. |
| |
Keywords: | Vaccine production Salmonella Paratyphi O-specific polysaccharide Polysaccharide purification Enteric fever vaccine |
本文献已被 ScienceDirect 等数据库收录! |
|